Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001741474-25-000006
Filing Date
2025-11-10
Accepted
2025-11-10 18:00:42
Documents
1
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1762815639.html 4  
1 FORM 4 wk-form4_1762815639.xml 4 5679
  Complete submission text file 0001741474-25-000006.txt   7215
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Issuer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Skovronsky Daniel (Reporting) CIK: 0001741474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06351 | Film No.: 251467672